Baxter International BAX Insider Ownership

NYSE BAX

$24.71 +0.20 (+0.82%)

As of: Oct 21, 2026 · 3:59 PM EDT

Insider Holdings by Owner

3.35Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.514%

▼-0.0049% pp QoQ

Shares Held by Insiders

2.66Mn

filed for Sep 2026

▼-0.94% QoQ

Shares Outstanding

517.00Mn

517,000,000 shares

Direct Holdings

2.66Mn

Indirect: 0

Net Shares Traded (QoQ)

-25.32K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 5, 2026

Over the past year, BAX insiders did not buy or sell the stock on the open market.

Away from the open market, BAX insiders received 452.39K shares in stock awards and gave up 124.62K shares to cover taxes or exercise prices over the last 12 months.
According to Business Quant data, insiders at Baxter International reported 2.66Mn shares in total in their latest Form 4 filings, or 0.51% of the 517Mn shares outstanding; that total is down 0.94% from 2.68Mn shares at the end of Q2 2026.
BAX's insiders hold all 2.66Mn shares directly, in their own names, with no indirect holdings.
Business Quant counts 27 insiders with holdings in Baxter International stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
BAX's largest insider holders by reported holdings are Andrew P. Hider (President and CEO, 518.45K shares), Joel T. Grade (EVP and CFO, 271.67K shares) and Jose E. Almeida (Chairman, CEO, President, 243.59K shares).
The largest insider, Andrew P. Hider, holds 19.51% of BAX's insider total.
In the past year, 19 insiders of Baxter International submitted 33 Form 4 filings reporting trades, awards or other transactions.
This summary of Baxter International insider activity covers Form 4 filings through September 3, 2026.

Form 4 Holdings

Insiders Holding BAX

Insiders 41

Shares held 3.35Mn

Of outstanding 0.647%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Andrew P. Hider	President And Ceo	518,447	518,447	15.5%	03 Sep, 2026
2	Joel T. Grade	Evp And Cfo	271,674	271,674	8.1%	10 Mar, 2026
3	Jose E Almeida	Chairman, Ceo, President	243,589	243,589	7.3%	17 Dec, 2024
4	Jeanne K Mason	Evp, Chief Hr Officer	199,853	199,853	6.0%	16 Dec, 2025
5	James Saccaro	Evp, Chief Financial Officer	177,899	177,899	5.3%	06 Mar, 2023
6	Heather Knight	Evp, Chief Operating Officer	177,362	177,362	5.3%	10 Mar, 2025
7	David S. Rosenbloom	Evp And General Counsel	138,216	138,216	4.1%	10 Mar, 2026
8	Alok Sonig	Evp,Group President,Pharma	128,219	128,219	3.8%	04 Sep, 2025
9	Reazur Rasul	Evp,Group Pres,Healthcare	125,557	125,557	3.8%	10 Mar, 2026
10	Christopher A. Toth	Evp, Group Pres, Kidney Care	105,186	105,186	3.1%	04 Feb, 2025
11	Cristiano Franzi	Svp, President, Emea	102,145	102,145	3.1%	06 Mar, 2023
12	Giuseppe Accogli	Evp, Chief Operating Officer	76,495	76,495	2.3%	04 Mar, 2022
13	Maria Cecilia Soriano	Group Pres., Itt Pharma.	75,045	75,045	2.2%	10 Mar, 2026
14	David Brent Shafer	Interim Ceo And Chair	72,804	72,804	2.2%	07 May, 2026
15	James W Borzi	Evp,Chief Supply Chain Officer	71,948	71,948	2.2%	04 Sep, 2025
16	Steven P. Wallace	President, Adv. Surgery	70,128	70,128	2.1%	03 Jun, 2026
17	Brian Stevens	Svp, Cao Controller	67,538	67,538	2.0%	08 Mar, 2024
18	Anita A Zielinski	Svp, Interim Cfo, Cao Cntrlr	59,714	59,714	1.8%	03 Jun, 2026
19	Sean Martin	Svp And General Counsel	52,632	52,632	1.6%	04 Mar, 2022
20	Amy Mcbride Wendell	Director	44,235	44,235	1.3%	07 May, 2026
21	Patricia Morrison	Director	42,386	42,386	1.3%	07 May, 2026
22	David S. Wilkes	Director	37,076	37,076	1.1%	07 May, 2026
23	Albert P L Stroucken	Director	36,835	36,835	1.1%	22 Mar, 2023
24	Stephen N. Oesterle	Director	35,847	35,847	1.1%	08 May, 2025
25	Nancy M Schlichting	Director	34,994	34,994	1.0%	07 May, 2026
26	William A. Ii Ampofo	Director	34,186	34,186	1.0%	07 May, 2026
27	Steven Flynn	Svp, President, Apac	31,080	31,080	0.9%	03 Mar, 2023
28	James Teaff	President, Ccs	30,370	30,370	0.9%	03 Sep, 2026
29	Cathy R Smith	Director	30,345	30,345	0.9%	08 May, 2025
30	Peter S Hellman	Director	30,335	30,335	0.9%	05 May, 2022
31	Cynthia Carlisle	Executive Vice President, Chro	29,677	29,677	0.9%	03 Mar, 2026
32	Julie Foster	President, Front Line Care	29,164	29,164	0.9%	03 Sep, 2026
33	John D Forsyth	Director	27,029	27,029	0.8%	05 Apr, 2022
34	Jeffrey A Craig	Director	23,662	23,662	0.7%	07 May, 2026
35	Jacqueline Kunzler	Svp, Chief Quality Officer	22,625	22,625	0.7%	06 Mar, 2023
36	Andrew Frye	Svp, President, Apac	22,002	22,002	0.7%	04 Mar, 2022
37	Stephen H Rusckowski	Director	16,499	16,499	0.5%	08 May, 2025
38	Thomas F Chen	Director	15,740	15,740	0.5%	05 May, 2022
39	Michael R. Mcdonnell	Director	14,647	14,647	0.4%	07 May, 2026
40	Peter M Wilver	Director	13,267	13,267	0.4%	09 May, 2024
41	Michael F Mahoney	Director	9,692	9,692	0.3%	04 May, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

2,425 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
01 Sep, 2026	James Teaff	President, Ccs	Disposed F	750	$25.48	$19.11K	30,370	Direct
02 Sep, 2026	Andrew P. Hider	President And Ceo	Disposed F	54,276	$25.70	$1.39Mn	518,447	Direct
02 Sep, 2026	Julie Foster	President, Front Line Care	Disposed F	2,098	$25.70	$53.92K	29,164	Direct
01 Jun, 2026	Anita A Zielinski	Svp, Interim Cfo, Cao Cntrlr	Acquired A	13,426	$0.00	$0	59,714	Direct
02 Jun, 2026	Steven P. Wallace	President, Adv. Surgery	Disposed F	153	$18.68	$2.86K	70,128	Direct
02 Jun, 2026	James Teaff	President, Ccs	Disposed F	321	$18.68	$6.00K	31,063	Direct
05 May, 2026	Michael R. Mcdonnell	Director	Acquired A	12,836	$0.00	$0	14,647	Direct
05 May, 2026	Patricia Morrison	Director	Acquired A	12,836	$0.00	$0	42,386	Direct
05 May, 2026	Nancy M Schlichting	Director	Acquired A	12,836	$0.00	$0	34,994	Direct
05 May, 2026	David Brent Shafer	Director, Other	Acquired A	12,836	$0.00	$0	72,804	Direct
05 May, 2026	Jeffrey A Craig	Director	Acquired A	12,836	$0.00	$0	23,662	Direct
05 May, 2026	David S. Wilkes	Director	Acquired A	12,836	$0.00	$0	37,076	Direct
05 May, 2026	Amy Mcbride Wendell	Director	Acquired A	12,836	$0.00	$0	44,235	Direct
05 May, 2026	William A. Ii Ampofo	Director	Acquired A	12,836	$0.00	$0	30,375	Direct
06 Mar, 2026	Anita A Zielinski	Svp, Cao And Controller	Disposed F	1,932	$17.69	$34.18K	46,281	Direct
06 Mar, 2026	David S. Rosenbloom	Evp And General Counsel	Disposed F	6,620	$17.69	$117.11K	138,216	Direct
06 Mar, 2026	Reazur Rasul	Evp,Group Pres,Healthcare	Disposed F	12,674	$17.69	$224.20K	125,557	Direct
06 Mar, 2026	Maria Cecilia Soriano	Group Pres., Itt Pharma.	Disposed F	2,848	$17.69	$50.38K	75,045	Direct
06 Mar, 2026	Joel T. Grade	Evp And Cfo	Disposed F	8,153	$17.69	$144.23K	271,674	Direct
27 Feb, 2026	Anita A Zielinski	Svp, Cao And Controller	Acquired A	30,864	$0.00	$0	48,214	Direct

Showing 1 to 20 of 2,425 transactions